Chiara Catania

ScholarGPS® ID: 46811811998486

Affiliation

European Institute of Oncology Milano, Italy

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

115

Predicted Citations

1,992

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research (journal article) Conforti, Fabio \| Pala, Laura \| De Pas, Tommaso \| Zattarin, Emma \| Catania, Chiara \| Cocorocchio, Emilia \| Rossi, Giovanna \| Laszlo, Daniele \| Colleoni, Marco \| Zambelli, Alberto \| ... \| Viale, Giuseppe Clinical Cancer Research, volume 30, issue 6, pages 1093-1103 (2024). 10.1158/1078-0432.CCR-23-1836 Cited by (1) \| Cite \| Source
“Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.” (journal article) Pala, Laura \| Sala, Isabella \| Pagan, Eleonora \| De Pas, Tommaso \| Zattarin, Emma \| Catania, Chiara \| Cocorocchio, Emilia \| Rossi, Giovanna \| Laszlo, Daniele \| Ceresoli, Giovanni \| ... \| Conforti, Fabio The Breast, volume 73 (2024). 10.1016/j.breast.2024.103672 Cite \| Source
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis (journal article) Pala, Laura \| De Pas, Tommaso \| Stucchi, Erika \| Catania, Chiara \| Cocorocchio, Emilia \| Zampino, Maria Giulia \| Rossi, Giovanna \| Zattarin, Emma \| Di Muzio, Antonio \| Laszlo, Daniele \| ... \| Conforti, Fabio Seminars in Oncology, volume 50, issue 6, pages 140-143 (2023). 10.1053/j.seminoncol.2023.11.002 Cite \| Source
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group (journal article) Catania, Chiara \| Filippi, Andrea Riccardo \| Sangalli, Claudia \| Piperno, Gaia \| Russano, Marco \| Greco, Carlo \| Scotti, Vieri \| Proto, Claudia \| Bennati, Chiara \| Di Pietro Paolo, Marzia \| ... \| Russo, Alessandro Critical Reviews in Oncology/Hematology, volume 190 (2023). 10.1016/j.critrevonc.2023.104108 Cited by (1) \| Cite \| Source
Outcomes of diffuse large/high grade B cell lymphoma patients following receipt of autologous stem transplantation or chimeric antigen receptor‐modified T cells (journal article) Landsburg, D. J. \| Nasta, S. D. \| Svoboda, J. \| Gerson, J. N. \| Schuster, S. J \| Barta, S. K \| Chong, E. A. \| Difilippo, H. \| Weber, E. \| Cunningham, K. \| ... \| Porter, D. L. Hematological Oncology, volume 41, issue S2, pages 448-449 (2023). 10.1002/hon.3164_330 Cite \| Source
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials (journal article) Pala, Laura \| De Pas, Tommaso \| Pagan, Eleonora \| Sala, Isabella \| Catania, Chiara \| Zattarin, Emma \| Arnone, Paolo \| Grassi, Massimo M. \| Colleoni, Marco \| Wolff, Antonio C. \| ... \| Conforti, Fabio The Breast, volume 69 (2023). 10.1016/j.breast.2023.02.012 Cited by (3) \| Cite \| Source
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review (journal article) Digiacomo, Nunzio \| De Pas, Tommaso \| Rossi, Giovanna \| Bossi, Paola \| Stucchi, Erika \| Conforti, Fabio \| Cocorocchio, Emilia \| Laszlo, Daniele \| Pala, Laura \| Zattarin, Emma \| Catania, Chiara Current Oncology, volume 30, issue 3, pages 3494-3499 (2023). 10.3390/curroncol30030265 Cite \| Source
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis (journal article) Pala, Laura \| De Pas, Tommaso \| Pagan, Eleonora \| Minucci, Saverio \| Catania, Chiara \| Digiacomo, Nunzio \| Cocorocchio, Emilia \| Laszlo, Daniele \| Di Muzio, Antonio \| Barigazzi, Chiara \| ... \| Conforti, Fabio Seminars in Oncology, volume 50, issue 1-2, pages 34-39 (2023). 10.1053/j.seminoncol.2023.03.003 Cited by (2) \| Cite \| Source
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study (journal article) Conforti, Fabio \| Pala, Laura \| Vivanet, Grazia \| Corti, Chiara \| Catania, Chiara \| Maiettini, Daniele \| Varano, Gianluca \| Di Venosa, Benedetta \| Curigliano, Giuseppe \| Salvini, Piermario \| ... \| De Pas, Tommaso Martino Lung Cancer, volume 176 (2023). 10.1016/j.lungcan.2023.01.004 Cite \| Source
Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers (journal article) Spitaleri, G. \| Trillo Aliaga, P. \| Catania, C. \| Signore, E. Del \| Attili, I. \| Santoro, C. \| Giugliano, F. \| Berton Giachetti, P.P.M \| Curigliano, G. \| Passaro, A. \| de Marinis, F. Clinical Lung Cancer, volume 24, issue 1, pages e19-e26 (2023). 10.1016/j.cllc.2022.10.004 Cite \| Source
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis (journal article) Pala, L. \| De Pas, T. \| Pagan, E. \| Catania, C. \| Bagnardi, V. \| Conforti, F. European Journal of Cancer, volume 174 (2022). 10.1016/S0959-8049(22)00817-6 Cite \| Source
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial (journal article) Conforti, Fabio \| Zucali, Paolo Andrea \| Pala, Laura \| Catania, Chiara \| Bagnardi, Vincenzo \| Sala, Isabella \| Della Vigna, Paolo \| Perrino, Matteo \| Zagami, Paola \| Corti, Chiara \| ... \| De Pas, Tommaso Martino The Lancet Oncology, volume 23, issue 10, pages 1287-1296 (2022). 10.1016/S1470-2045(22)00542-3 Cited by (23) \| Cite \| Source
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group (journal article) Antonarelli, Gabriele \| Corti, Chiara \| Zucali, Paolo Andrea \| Perrino, Matteo \| Manglaviti, Sara \| Lo Russo, Giuseppe \| Varano, Gianluca Maria \| Salvini, Piermario \| Curigliano, Giuseppe \| Catania, Chiara \| ... \| De Pas, Tommaso European Journal of Cancer, volume 174 (2022). 10.1016/j.ejca.2022.07.009 Cited by (10) \| Cite \| Source
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy (journal article) Corti, Chiara \| Conforti, Fabio \| Pala, Laura \| Catania, Chiara \| Cocorocchio, Emilia \| Ferrucci, Pier Francesco \| Curigliano, Giuseppe \| Queirolo, Paola \| de Pas, Tommaso European Journal of Cancer, volume 172 (2022). 10.1016/j.ejca.2022.06.015 Cited by (7) \| Cite \| Source
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50% (journal article) Attili, Ilaria \| Valenza, Carmine \| Santoro, Celeste \| Antonarelli, Gabriele \| Trillo Aliaga, Pamela \| Del Signore, Ester \| Catania, Chiara \| Spitaleri, Gianluca \| Passaro, Antonio \| de Marinis, Filippo Frontiers in Oncology, volume 12 (2022). 10.3389/fonc.2022.980765 Cited by (6) \| Cite \| Source
Sex and cancer immunotherapy: Current understanding and challenges (journal article) Pala, Laura \| De Pas, Tommaso \| Catania, Chiara \| Giaccone, Giuseppe \| Mantovani, Alberto \| Minucci, Saverio \| Viale, Giuseppe \| Gelber, Richard D. \| Conforti, Fabio Cancer Cell, volume 40, issue 7, pages 695-700 (2022). 10.1016/j.ccell.2022.06.005 Cited by (18) \| Cite \| Source
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era (journal article) Catania, Chiara \| Piperno, Gaia \| Russo, Alessandro \| Greco, Carlo \| Agustoni, Francesco \| Scotti, Vieri \| Proto, Claudia \| Sangalli, Claudia \| Patani, Fabiola \| Santacaterina, Anna \| ... \| Ramella, Sara Critical Reviews in Oncology/Hematology, volume 174 (2022). 10.1016/j.critrevonc.2022.103684 Cited by (2) \| Cite \| Source
42P Comparative real-world analysis of pembrolizumab plus chemo vs platinum-doublet alone in metastatic non-squamous NSCLC with PD-L1 low (journal article) Attili, I. \| Valenza, C. \| Santoro, C. \| Antonarelli, G. \| Trillo Aliaga, P. \| Del Signore, E. \| Catania, C. \| Spitaleri, G. \| Passaro, A. \| de Marinis, F. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.02.051 Cite \| Source
The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature (journal article) Catania, Chiara \| Muthusamy, Bharathi \| Spitaleri, Gianluca \| del Signore, Ester \| Pennell, Nathan A. Clinical Lung Cancer, volume 23, issue 2, pages 108-115 (2022). 10.1016/j.cllc.2021.11.003 Cited by (8) \| Cite \| Source
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials (journal article) Conforti, F. \| Pala, L. \| Pagan, E. \| Corti, C. \| Bagnardi, V. \| Queirolo, P. \| Catania, C. \| De Pas, T. \| Giaccone, G. ESMO Open, volume 6, issue 5, pages 100251- (2021). 10.1016/j.esmoop.2021.100251 Cited by (39) \| Cite \| Source